Differential Interaction of Peripheral Blood Lymphocyte Counts (ALC) With Different
absolute lymphocyte counts
acute myeloid leukemia
alemtuzumab
allogeneic stem cell transplant
antithymocyte globulin
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2019
2019
Historique:
received:
25
02
2019
accepted:
24
06
2019
entrez:
30
7
2019
pubmed:
30
7
2019
medline:
30
7
2019
Statut:
epublish
Résumé
Dosing regimens for antithymocyte globulin (ATG) and anti-CD52 antibody (alemtuzumab) for graft vs. host disease prophylaxis (GVHD) are empiric or weight-based, and do not account for individual patient factors. Recently, it has been shown that recipient peripheral blood absolute lymphocyte count (ALC) on the day of ATG administration interacts with the dose of ATG administered to predict transplantation outcome. Similarly, we wanted to analyze if the recipient ALC interacts with alemtuzumab dosing to predict outcomes. We retrospectively compared 364 patients, 124 patients receiving ATG (anti-thymocyte globulin) for GVHD prophylaxis, and undergoing unrelated first allogeneic transplant for myeloid and lymphoid malignancies (group 1) to 240 patients receiving alemtuzumab (group 2), in similar time period. There was no difference in survival or acute and chronic GVHD between 60 and 100 mg of alemtuzumab dosing. Unlike ATG (where the pre-transplant recipient ALC interacted with ATG dose on day of its administration (day 1) to predict OS and DFS (
Identifiants
pubmed: 31355140
doi: 10.3389/fonc.2019.00623
pmc: PMC6636242
doi:
Types de publication
Journal Article
Langues
eng
Pagination
623Références
Bone Marrow Transplant. 1999 Aug;24(3):283-7
pubmed: 10455367
Blood. 2001 Nov 15;98(10):2942-7
pubmed: 11698275
Cytotherapy. 2001;3(4):261-7
pubmed: 12171714
Bone Marrow Transplant. 2002 Apr;29(8):683-9
pubmed: 12180114
Blood. 2002 Nov 1;100(9):3121-7
pubmed: 12384408
Blood. 2003 Jul 15;102(2):470-6
pubmed: 12649133
Exp Hematol. 2003 Nov;31(11):1026-30
pubmed: 14585365
Br J Haematol. 2004 Apr;125(2):217-24
pubmed: 15059145
Blood. 2004 Sep 15;104(6):1616-23
pubmed: 15059843
Bone Marrow Transplant. 2004 Jul;34(2):137-42
pubmed: 15235576
Transplantation. 2004 Jul 15;78(1):122-7
pubmed: 15257050
Exp Hematol. 2005 Aug;33(8):920-7
pubmed: 16038785
Biol Blood Marrow Transplant. 2006 Sep;12(9):919-27
pubmed: 16920557
Clin Cancer Res. 2006 Dec 1;12(23):7174-9
pubmed: 17145843
Br J Clin Pharmacol. 2007 Sep;64(3):278-91
pubmed: 17506867
Bone Marrow Transplant. 2007 Aug;40(4):381-7
pubmed: 17563735
Biol Blood Marrow Transplant. 2007 Oct;13(10):1216-23
pubmed: 17889359
Stat Med. 2009 Jun 30;28(14):1957-66
pubmed: 19378282
Blood. 2009 Jul 16;114(3):702-8
pubmed: 19470693
Biol Blood Marrow Transplant. 2009 Sep;15(9):1108-15
pubmed: 19660724
Lancet Oncol. 2009 Sep;10(9):855-64
pubmed: 19695955
Biol Blood Marrow Transplant. 2009 Nov;15(11):1422-30
pubmed: 19822302
Blood. 2010 Jan 21;115(3):453-74
pubmed: 19880497
Bone Marrow Transplant. 2010 Jul;45(7):1212-9
pubmed: 19966846
J Clin Oncol. 2010 Feb 20;28(6):1011-6
pubmed: 20065176
Blood. 2010 Oct 21;116(16):3080-8
pubmed: 20587785
J Clin Oncol. 2011 Jun 1;29(16):2230-9
pubmed: 21464398
Blood. 2011 Jun 9;117(23):6375-82
pubmed: 21467544
Blood. 2012 Jan 5;119(1):296-307
pubmed: 22010102
Bone Marrow Transplant. 2012 Nov;47(11):1459-64
pubmed: 22410750
Biol Blood Marrow Transplant. 2012 Nov;18(11):1664-1676.e1
pubmed: 22698485
Blood. 2012 Jul 26;120(4):905-13
pubmed: 22709687
Biol Blood Marrow Transplant. 2013 Feb;19(2):305-13
pubmed: 23092812
Bone Marrow Transplant. 2013 Jun;48(6):803-8
pubmed: 23178547
Biol Blood Marrow Transplant. 2014 Jan;20(1):111-7
pubmed: 24216184
Biol Blood Marrow Transplant. 2014 Apr;20(4):507-17
pubmed: 24406505
Leuk Lymphoma. 2015 Apr;56(4):1058-65
pubmed: 25166008
Biol Blood Marrow Transplant. 2015 Mar;21(3):473-82
pubmed: 25485863
Biol Blood Marrow Transplant. 2015 Aug;21(8):1460-70
pubmed: 25865646
Biol Blood Marrow Transplant. 2015 Aug;21(8):1343-59
pubmed: 25985921
Blood. 2015 Dec 24;126(26):2882-91
pubmed: 26450984
Biol Blood Marrow Transplant. 2016 Mar;22(3):456-61
pubmed: 26524732
Blood. 2016 Jan 28;127(4):503-12
pubmed: 26644451
Lancet Haematol. 2015 May;2(5):e194-203
pubmed: 26688094
Blood. 2016 Dec 8;128(23):2734-2741
pubmed: 27702800
Biol Blood Marrow Transplant. 2017 Feb;23(2):293-299
pubmed: 27816648
Biol Blood Marrow Transplant. 2017 Apr;23(4):635-641
pubmed: 28089878
Lancet Haematol. 2017 Apr;4(4):e183-e191
pubmed: 28330607
Biol Blood Marrow Transplant. 2018 Jan;24(1):150-155
pubmed: 28864139
J Clin Oncol. 2017 Dec 20;35(36):4003-4011
pubmed: 29040031
Am J Hematol. 2019 Jan;94(1):93-102
pubmed: 30370942
Biol Blood Marrow Transplant. 2019 Apr;25(4):639-647
pubmed: 30572108
Blood. 1995 Aug 15;86(4):1487-92
pubmed: 7632956
Int Immunol. 1996 Mar;8(3):325-34
pubmed: 8671618
Immunology. 1998 Nov;95(3):427-36
pubmed: 9824507